The Systematic Coronary Risk Evaluation 2 (SCORE2) predicts 10-year CVD risk in patients without prior CVD or diabetes.

Discover the two algorithms, SCORE2 and SCORE2-OP (older persons, published in June 2021 to estimate the 10-year risk of cardiovascular disease in Europe.

SCORE2-Older Persons (SCORE2-OP) predicts 10-year CVD risk in older patients.

HeartScore is now updated with the SCORE2 and SCORE2-OP algorithms with recommendations for physicians and patients, from the 2021 ESC Guidelines on CVD Prevention in Clinical Practice. Calculate 10-year risk of fatal and non-fatal cardiovascular disease events. No …

SCORE2-Diabetes predicts 10-year CVD risk in patients with type 2 diabetes.

2021年6月13日 · SCORE2—a new algorithm derived, calibrated, and validated to predict 10-year risk of first-onset CVD in European populations—enhances the identification of individuals at higher risk of developing CVD across Europe.

About the calculator: The SCORE2 and SCORE2-OP risk assessment models (we call SCORE2 in this website) to estimate 10-year risk of cardiovascular disease in Europe did not take into account any measures of kidney disease.

The SCORE2-OP algorithm estimates 5-year and 10-year fatal and non-fatal CVD events (myocardial infarction, stroke) adjusted for competing risks in apparently healthy people aged ≥70 years.

2021年6月21日 · SCORE2, an updated algorithm tailored to European populations, provides risk estimates for the combined outcome of fatal and nonfatal cardiovascular disease (CVD) events, in contrast with SCORE’s use of CVD mortality only.

SCORE2 provides risk estimates for the combined outcome of fatal and nonfatal CVD events, in contrast with SCORE’s use of only CVD mortality. Furthermore, SCORE2 has been systematically recalibrated, using the most contemporary and representative CVD rates available, whereas the original SCORE model was based on data col-lected before 1986.